Compare MRK & AVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRK | AVGO |
|---|---|---|
| Founded | 2000 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 2.0T |
| IPO Year | 1994 | 2018 |
| Metric | MRK | AVGO |
|---|---|---|
| Price | $120.79 | $386.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 30 |
| Target Price | $125.59 | ★ $443.14 |
| AVG Volume (30 Days) | 6.9M | ★ 18.6M |
| Earning Date | 04-30-2026 | 06-04-2026 |
| Dividend Yield | ★ 3.06% | 0.64% |
| EPS Growth | 8.01 | ★ 287.80 |
| EPS | N/A | ★ 1.50 |
| Revenue | ★ $65,011,000,000.00 | $20,848,000,000.00 |
| Revenue This Year | $3.61 | $67.53 |
| Revenue Next Year | $5.41 | $53.74 |
| P/E Ratio | ★ N/A | $278.79 |
| Revenue Growth | 1.31 | ★ 18.21 |
| 52 Week Low | $76.66 | $244.18 |
| 52 Week High | $125.14 | $495.00 |
| Indicator | MRK | AVGO |
|---|---|---|
| Relative Strength Index (RSI) | 60.69 | 40.17 |
| Support Level | $112.49 | $312.06 |
| Resistance Level | $124.09 | $401.24 |
| Average True Range (ATR) | 2.82 | 16.67 |
| MACD | 0.45 | -3.60 |
| Stochastic Oscillator | 83.03 | 0.58 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing and networking, with custom AI accelerators now accounting for the bulk of the business. It is primarily a fabless designer, but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.